Cerus (CERS) Receivables - Other (2018 - 2021)
Cerus' (CERS) quarterly Receivables - Other came in at $2.7 million in Q3 2021, down 53.09% quarter-over-quarter from $5.7 million in Q2 2021.
Analysis
Cerus (CERS) Receivables - Other (2018 - 2021) Analysis & Trends
Cerus has disclosed Receivables - Other across 3 years of filings, most recently posting $2.7 million for Q3 2021.
- In Q3 2021, Receivables - Other changed N/A year-over-year to $2.7 million; the TTM figure through Sep 2021 stood at $2.7 million (changed N/A YoY), while the FY2020 annual figure was $2.4 million, changed N/A from the prior year.
- Receivables - Other came in at $2.7 million for Q3 2021 at Cerus, down from $5.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $5.7 million in Q2 2021 to a low of $1.2 million in Q4 2018.
- Average Receivables - Other over 3 years is $3.0 million, with a median of $2.7 million recorded in 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Cerus | 504.42 Mn | 448.16 Mn | 29.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 5.68 Mn |
| Mar 31, 2021 | 3.30 Mn |
| Dec 31, 2020 | 2.38 Mn |
| Dec 31, 2018 | 1.20 Mn |